Intravesical combination therapies for non-muscle invasive bladder cancer: Recent advances and future directions-Reference-Cited by-同舟云学术

Intravesical combination therapies for non-muscle invasive bladder cancer: Recent advances and future directions

Published:2022-07 Issue: Volume:926 Page:175024
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Li You,Youssef Shams F.,Buanz Asma BM.^ORCID

Publisher

Elsevier BV

Subject

Pharmacology

Reference111 articles.

1. Influence of intravesical potassium on pelvic floor activity in women with recurrent urinary tract infections: comparative urodynamics might lead to enhanced detection of dysfunctional voiding;Akkad;BJU Int.,2007

2. MP43-09 phase I trial of intravesical Bacillus Calmette-Guérin combined with intravenous pembrolizumab in high grade nonmuscle invasive bladder cancer;Alanee;J. Urol.,2019

3. Combined chemohyperthermia: 10-year single center experience in 160 patients with nonmuscle invasive bladder cancer;Arends;J. Urol.,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential bladder cancer therapeutic delivery systems: a recent update;Expert Opinion on Drug Delivery;2024-09-11

2. Tumor microenvironment-modulating oncolytic adenovirus combined with GSK-3β inhibitor enhances antitumor immune response against bladder cancer;Frontiers in Immunology;2024-05-15

3. Symptom management and nursing interventions for postoperative bladder instillation chemotherapy in bladder cancer patients;Minerva Surgery;2023-12

4. Recent advancements in the diagnosis and treatment of non‐muscle invasive bladder cancer: Evidence update of surgical concept, risk stratification, and BCG‐treated disease;International Journal of Urology;2023-07-31

5. Comparative transcriptomic analysis and mechanistic characterization revealed the use of formononetin for bladder cancer treatment;Food & Function;2023